Progressive multifocal leukoencephalopathy-remission with cytarabine.

Abstract

A 51-year-old woman who was in complete remission from non-Hodgkin's lymphoma, developed a rapidly progressive dementia. Progressive multifocal leukoencephalopathy (PML) was diagnosed on the basis of a rising antibody titre to JC polyomavirus in cerebro-spinal fluid and serum and the presence of diffuse white matter changes on magnetic resonance imaging. She was treated initially with intravenous cytarabine and showed minimal improvement. Rapid improvement occurred when intrathecal cytarabine was added and the patient is in complete remission from both lymphoma and PML 20 months later.

• Authors: T O'Riordan, P A Daly, M Hutchinson, A G Shattock, S D Gardner
• Journal: The Journal of infection (J Infect) Vol. 20 Issue 1 Pg. 51-4 (Jan 1990) ISSN: 0163-4453 [Print] England
• PMID: 2153729 (Publication Type: Case Reports, Journal Article)

Chemical References

• Cytarabine

Topics

• Cytarabine (administration & dosage, therapeutic use)
• Drug Administration Schedule
• Female
• Humans
• Injections, Intravenous
• JC Virus (analysis, immunology)
• Leukoencephalopathy, Progressive Multifocal (diagnosis, drug therapy)
• Magnetic Resonance Imaging
• Middle Aged
• Remission Induction